Unknown

Dataset Information

0

Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation.


ABSTRACT: Glucocorticoids are beneficial in many muscular dystrophies but they are ineffective in treating dysferlinopathy, a rare muscular dystrophy caused by loss of dysferlin. We sought to understand the molecular basis for this disparity by studying the effects of a glucocorticoid on differentiation of the myoblast cell line, C2C12, and dysferlin-deficient C2C12s. We found that pharmacologic doses of dexamethasone enhanced the myogenic fusion efficiency of C2C12s and increased the induction of dysferlin, along with specific myogenic transcription factors, sarcolemmal and structural proteins. In contrast, the dysferlin-deficient C2C12 cell line demonstrated a reduction in long myotubes and early induction of particular muscle differentiation proteins, most notably, myosin heavy chain. Dexamethasone partially reversed the defect in myogenic fusion in the dysferlin-deficient C2C12 cells. We hypothesize that a key therapeutic benefit of glucocorticoids may be the up-regulation of dysferlin as an important component of glucocorticoid-enhanced myogenic differentiation.

SUBMITTER: Belanto JJ 

PROVIDER: S-EPMC2856642 | biostudies-literature | 2010 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation.

Belanto Joseph J JJ   Diaz-Perez Silvia V SV   Magyar Clara E CE   Maxwell Michele M MM   Yilmaz Yasemin Y   Topp Kasey K   Boso Guney G   Jamieson Catriona H CH   Cacalano Nicholas A NA   Jamieson Christina A M CA  

Neuromuscular disorders : NMD 20100118 2


Glucocorticoids are beneficial in many muscular dystrophies but they are ineffective in treating dysferlinopathy, a rare muscular dystrophy caused by loss of dysferlin. We sought to understand the molecular basis for this disparity by studying the effects of a glucocorticoid on differentiation of the myoblast cell line, C2C12, and dysferlin-deficient C2C12s. We found that pharmacologic doses of dexamethasone enhanced the myogenic fusion efficiency of C2C12s and increased the induction of dysferl  ...[more]

Similar Datasets

| S-EPMC10213057 | biostudies-literature
| S-EPMC4836019 | biostudies-literature
| S-EPMC3923792 | biostudies-literature
| S-EPMC9136495 | biostudies-literature
| S-EPMC3364732 | biostudies-literature
| S-EPMC6695777 | biostudies-literature
| S-EPMC7498330 | biostudies-literature
| S-EPMC7260857 | biostudies-literature
| S-EPMC11310181 | biostudies-literature
| S-EPMC8891624 | biostudies-literature